http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109232609-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
filingDate 2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109232609-B
titleOfInvention Method for preparing high-purity cefpodoxime proxetil
abstract The inventionDisclosed is a method for preparing high-purity cefpodoxime proxetil, comprising: under the action of carbonate and alkaline ionic liquid, cefpodoxime acid and iodoester react in an organic solvent, and the cefpodoxime proxetil is obtained through post-treatment after the reaction is finished. The cefpodoxime proxetil product obtained by the method has less than 3 percent of total impurities and delta 3 Less than 1.5 percent of isomer (total impurities are less than 4 percent according to EP7.0 and less than 6 percent according to USP 35), good product stability, high yield, high molar yield of 78.3 to 83.7 percent, simple operation and suitability for industrial production.
priorityDate 2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5498787-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448034966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452842836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44253791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453375181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420966385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20498196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413782405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413574351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11788435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21932263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452650124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450135816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 53.